US Stock MarketDetailed Quotes

AGIO Agios Pharmaceuticals

Watchlist
  • 35.420
  • -0.390-1.09%
Close Dec 20 16:00 ET
  • 35.420
  • 0.0000.00%
Post 20:01 ET
2.02BMarket Cap3.04P/E (TTM)

About Agios Pharmaceuticals Company

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Company Profile

SymbolAGIO
Company NameAgios Pharmaceuticals
Listing DateJul 24, 2013
Issue Price18.00
Founded2007
CEOMr. Brian Goff
MarketNASDAQ
Employees386
Fiscal Year Ends12-31
Address88 Sidney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139-4169
Phone1-617-649-8600

Company Executives

  • Name
  • Position
  • Salary
  • Brian Goff
  • Chief Executive Officer and Director
  • 3.42M
  • James William Burns
  • Chief Legal Officer
  • 1.93M
  • Cecilia Jones
  • Chief Financial Officer
  • 1.21M
  • Dr. Sarah Gheuens, M.D.,PhD
  • Chief Medical Officer and Head of Research and Development
  • 2.87M
  • Tsveta Milanova
  • Chief Commercial Officer
  • 3.73M
  • T. J. Washburn
  • Principal Accounting Officer, Vice President and Controller
  • --
  • Dr. Jacqualyn A. Fouse, PhD
  • Chairman of the Board
  • 447.25K
  • Cynthia Smith
  • Independent Director
  • 419.91K
  • Dr. Rahul D. Ballal, PhD
  • Independent Director
  • 427.25K
  • Kaye Foster
  • Lead Independent Director
  • 440.95K
  • Jeffrey D. Capello
  • Independent Director
  • 663.68K
  • Catherine Owen
  • Independent Director
  • 659.94K
  • Dr. David P. Schenkein, M.D.
  • Independent Director
  • 417.25K
  • Dr. Maykin Ho, PhD
  • Independent Director
  • 424.75K
  • Dr. David T. Scadden, M.D.
  • Independent Director
  • 429.75K
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.